Synthesis 2011(1): 133-141  
DOI: 10.1055/s-0030-1258339
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

3-Methoxalylchromone - A Versatile Reagent for the Regioselective Synthesis of 1-Desazapurine

Dmytro Ostrovskyia, Viktor O. Iaroshenko*a,b,c, Iftikhar Alia, Satenik Mkrtchyana, Alexander Villingera, Andrei Tolmachevb,c, Peter Langer*a,d
a Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany
Fax: +49(381)4986412; e-Mail: viktor.iaroshenko@uni-rostock.de; e-Mail: iva108@googlemail.com;
b National Taras Shevchenko University, 62 Volodymyrska st., Kyiv-33, 01033, Ukraine
c ‘Enamine Ltd.’, 23 A. Matrosova st., 01103 Kyiv, Ukraine
Fax: +380(44)5373253; e-Mail: yaroshenko@enamine.net ;
d Leibniz-Institut für Katalyse e. V. an der Universität Rostock, Albert-Einstein-Str. 29a, 18059 Rostock, Germany
Further Information

Publication History

Received 7 October 2010
Publication Date:
26 November 2010 (eFirst)

Abstract

The reaction of 5-amino-1H-imidazoles with 3-methoxalylchromone provided a set of imidazo[4,5-b]pyridines (1-des­azapurines) bearing the CO2Me substituent at the α-position of the pyridine core. The corresponding acids were synthesized by subsequent hydrolysis of the ester function. Being typical purine isos­teres, 1-desazapurines are considered to be potent pharmacophores, and are widely used in drug design and medicinal chemistry.

    References

  • 1a Middleton WR. Wibberley DG. J. Heterocycl. Chem.  1980,  17:  1757 ; and references therein
  • 1b Bukowski L. Janowiec M. Pharmazie  1988,  43:  315 ; and references therein
  • 1c Chakravarty PK. Naylor EM. Chen A. Chang RSL. Chen T. Faust KA. Lotti VJ. Kivlighn SD. Gable RA. Zingaro GJ. Schorn TW. Schaffer LW. Broten TP. Siegl PKS. Patchett AA. Greenlee WJ. J. Med. Chem.  1994,  37:  4068 ; and references therein
  • 1d Mantlo NB. Chakravarty PK. Ondeyka DL. Siegl PKS. Chang R.-S. Lotti VJ. Faust KA. Chen TB. Schirn TW. Sweet CS. Emmert SE. Patchett AA. Greenlee WJ. J. Med. Chem.  1991,  34:  919 ; and references therein
  • 1e Mederski WKR. Pachler KGR. Tetrahedron  1992,  48:  10549 
  • 1f For a recent review on the biological activity of imidazo[4,5-b]pyridines, see: Dubey PK. Kumar RV. Naidu A. Kulkarni SM. Asian J. Chem.  2002,  14:  1129 
  • 2a Duncia JV. Carini DJ. Chiu AT. Johnson AL. Price WA. Wong PC. Wexler RR. Timmermans PBMW. Med. Res. Rev.  1992,  12:  149 
  • 2b De Laszlo SE. Quagliato CS. Greenlee WJ. Patchett AA. Chang RSL. Lotti VJ. Chen T.-B. Scheck SA. Faust KA. Kivlighn SS. Schorn TS. Zingaro GJ. Siegl PKS. J. Med. Chem.  1993,  36:  3207 ; and references therein
  • 2c Curtin ML. Davidsen SK. Heyman HR. Garland RB. Sheppard GS. Florjancic AS. Xu L. Carrera GM. Steinman DH. Trautmann JA. Albert DH. Magoc TJ. Tapang P. Rhein DA. Conway RG. Luo G. Denissen JF. Marsh KC. Morgan DW. Summers JB. J. Med. Chem.  1998,  41:  74 
  • 2d Janssens F. Torremans J. Janssen M. Stokbroekx RA. Luyckx M. Janssen PAJ. J. Med. Chem.  1985,  28:  1943 
  • 3 Clark RL. Pessolano AA. Shen T.-Y. Jocobus DP. Jones H. Lotti VJ. Flataker LM. J. Med. Chem.  1978,  21:  965 
  • 4 Robinson MM, and Finch N. inventors; U.S. Patent  3719683.  1973
  • 5 Von Bebenberg W. inventors; U.S. Patent  3819640.  1974
  • 6 Lesher GY, Brundage RP, Opalka CJ, and Page DF. inventors; French Patent  2,478,637.  1981; Chem. Abstr. 1982, 96, 85551k
  • 7 Kuezynski L. Mrozikiewiez A. Poreba K. Pol. J. Pharmacol. Pharm.  1982,  34:  229 
  • 8 Bianchi M. Butti A. Rossi S. Barzaghi F. Marcaria V. Eur. J. Med. Chem.  1983,  18:  501 
  • 9a Vaughn JR. inventors; U.S. Patent  2637731.  1953
  • 9b Röchling HFW, Büchel K.-H, and Korte FWAGK. inventors; U.S. Patent  3459759.  1969
  • 10a Wexler RR. Greenlee WJ. Irvin JD. Goldberg MR. Prendergast K. Smith RD. Timmermans PBMWM. J. Med. Chem.  1996,  39:  625 
  • 10b Schmidt B. Schieffer B. J. Med. Chem.  2003,  46:  2261 ; and references therein
  • 11a Mantlo NB. Chakravarty PK. Ondeyka DL. Siegl PKS. Chang RS. Lotti VJ. Faust KA. Chen T.-B. Schorn TW. Sweet CS. Emmert SE. Patchett AA. Greenlee WJ. J. Med. Chem.  1991,  34:  2919 
  • 11b Kim D. Mantlo NB. Chang RS. Kivlighn SD. Greenlee WJ. Bioorg. Med. Chem. Lett.  1994,  4:  41 
  • 11c Mantlo NB. Chang RSL. Siegl PKS. Bioorg. Med. Chem. Lett.  1993,  3:  1693 
  • 12a Rizzo M. Ventrice D. Monforte F. Procopio S. De Sarro G. Anzini M. Cappelli A. Makovec F. J. Pharm. Biomed. Anal.  2004,  35:  321 
  • 12b Rizzo M. Anzini M. Cappelli A. Vomero S. Ventrice D. De Sarro G. Procopio S. Costa N. Makovec F. Farmaco  2003,  58:  837 
  • 13a Bavetsias V. Sun C. Bouloc N. Reynisson J. Workman P. Linardopoulos S. McDonald E. Bioorg. Med. Chem. Lett.  2007,  17:  6567 
  • 13b Chan F. Sun C. Perumal M. Nguyen Q.-D. Bavetsias V. McDonald E. Martins V. Wilsher N. Valenti M. Eccles S. Poele R. Workman P. Aboagye EO. Linardopoulos S. Mol. Cancer Ther.  2007,  6:  3147 
  • 14a Cristalli G. Costanzi S. Lambertucci C. Lupidi G. Vittori S. Volpini R. Camaioni E. Med. Res. Rev.  2001,  21:  105 
  • 14b Maydanovych O. Beal PA. Chem. Rev.  2006,  106:  3397 
  • 14c Nair V. IMPDH inhibitors: Discovery of antiviral agents against emerging diseases, In Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats   Torrence PF. John Wiley & Sons, Inc; Hoboken: 2005.  Chap. 8. p.179-202  
  • 14d Shu Q. Nair V. Med. Res. Rev.  2008,  219 
  • 14e Erion MD. Reddy MR. J. Am. Chem. Soc.  1998,  120:  3295 
  • 15 Hedstrom L. Chem. Rev.  2009,  109:  2903 
  • 16a Ghosh CK. J. Heterocycl. Chem.  1983,  20:  1437 
  • 16b Sabitha G. Aldrichimica Acta  1996,  29:  15 
  • 16c Sosnovskikh VYa. Moshkin VS. Kodess MI. Tetrahedron Lett.  2008,  49:  6856 
  • 17 Volochnyuk DM. Ryabukhin SV. Plaskon AS. Grygorenko OO. Synthesis  2009,  3719 
  • 18 Mkrtchyan S. Iaroshenko VO. Dudkin S. Gevorgyan A. Vilches-Herrera M. Ghazaryan G. Volochnyuk DM. Ostrovskyi D. Zeeshan A. Villinger A. Sosnovskikh VY. Langer P. Org. Biomol. Chem.  2010,  8:  5280 
  • 19a Iaroshenko VO. Sevenard DV. Kotljarov AV. Volochnyuk DM. Tolmachev AO. Sosnovskikh VYa. Synthesis  2009,  731 
  • 19b Iaroshenko VO. Wang Y. Sevenard DV. Volochnyuk DM. Synthesis  2009,  1851 
  • 19c Iaroshenko VO. Sevenard DV. Volochnyuk DM. Wang Y. Martiloga A. Tolmachev AO. Synthesis  2009,  1865 
  • 19d Iaroshenko VO. Wang Y. Zhang B. Volochnyuk DM. Sosnovskikh VYa. Synthesis  2009,  2393 
  • 19e Kotljarov A. Irgashev RA. Iaroshenko VO. Sevenard DV. Sosnovskikh VYa. Synthesis  2009,  3233 
  • 19f Kotljarov A. Iaroshenko VO. Volochnyuk DM. Irgashev RA. Sosnovskikh VYa. Synthesis  2009,  3869 
  • 19g Iaroshenko VO. Synthesis  2009,  3967 
  • 19h Ostrovskyi D. Iaroshenko VO. Petrosyan A. Dudkin S. Ali I. Villinger A. Tolmachev A. Langer P. Synlett  2010,  2299 
  • 20a Gammill RB. Synthesis  1979,  901 
  • 20b Yokoe I. Maruyama K. Sugita Y. Harashida T. Shirataki Y. Chem. Pharm. Bull.  1994,  42:  1697 
21

Crystallographic data (excluding structure factors) for the structures of 7a and 9b, reported in this paper, have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC 799366 for 7a and CCDC 799367 for 9b. These data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44 (1223)336033; E-mail: deposit@ccdc.cam.ac.uk, or via www.ccdc.cam.ac.uk/data_request/cif

22

Iaroshenko, V. O.; Mkrtchyan, S.; Ghazaryan, G.; Hakopyan, A.; Maalik, A.; Supe, L.; Ostrovskyi, D.; Villinger, A.; Tolmachev, A.; Sosnovskikh, V. Ya.; Langer, P. manuscript in preparation.